B. Villarrealramos et al., IMMUNE-RESPONSES IN CALVES IMMUNIZED ORALLY OR SUBCUTANEOUSLY WITH A LIVE SALMONELLA-TYPHIMURIUM ARO VACCINE, Vaccine, 16(1), 1998, pp. 45-54
Salmonella aro vaccines ar-e able to confer solid protection against h
omologous virulent challenge in several animal species. Calves were pr
otected against virulent S. typhimurium challenge following administra
tion of a single oral dose of live BRD562 vaccine. Immune responses el
icited by the S, typhimurium aro vaccine strain BRD562 were studied fo
llowing administration to calves by either the oral or subcutaneous ro
ute, Serum antibodies to Salmonella polypeptides, following or-al or s
ubcutaneous vaccination, were detected by immunoblotting and the route
of inoculation found to affect both the antibody isotype and the anti
gens defected Oral, but not subcutaneous, immunisation induced bovine
serum IgA antibodies against Salmonella antigens of 30 kDa and 65 kDa
and bovine IgG2 antibodies against a 35 kDa antigen. Subcutaneous vacc
ination triggered responses against antigens of 52 kDa, 54 kDa and 57k
Da which were not detected by immune plasma of animals immunised orall
y Antibody responses to LPS were poor in animals inoculated by either
route. Subcutaneous vaccination elicited T-cell responses against Salm
onella antigens as measured by in vitro peripheral blood cell thymidin
e incorporation These studies show that the S, typhimurium vaccine str
ain BRD562 is capable of inducing both humoral and cellular immune res
ponses. Further studies are necessary to identity the nature of the an
tigens responsible for protection. Oral or subcutaneous inoculation of
BRD562(pTETnir15) failed to induce serum antibodies against the fragm
ent C of tetanus toxin (TetC) but was effective in mice. Oral vaccinat
ion with this recombinant vaccine induced mucosal IgA against TetC, Th
is is the first time that Salmonella recombinant vaccines have been sh
own to successfully elicit antibodies against a guest antigen in cattl
e after one single oral inoculation, (C) 1997 Elsevier-Science Ltd.